Sign in

CIK 0002035832 · <br>Emerging growth company

Aktis Oncology, Inc.

Sign in to watch
Ticker
AKTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
852584233
Phone
978-237-4380
Business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$258,621
in 1 filing, $259K under 10b5-1 plans

Net −$258,621. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Czibere Akos −$259K Chief Medical Officer sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2026-01-12 GADICKE ANSBERT 10% owner Conversion +1,577,119 9,147,287
2026-01-12 GADICKE ANSBERT 10% owner Purchase +1,112,777 $18.00 $20.0M 10,260,064
2026-01-12 GADICKE ANSBERT 10% owner Conversion · Series Seed Redeemable Convertible Preferred Stock −5,000,000 0
2026-01-12 GADICKE ANSBERT 10% owner Conversion · Series A Redeemable Convertible Preferred Stock −22,500,000 0
2026-01-12 GADICKE ANSBERT 10% owner Conversion · Series B Redeemable Convertible Preferred Stock −6,000,000 0
2026-01-12 Vida Ventures II, LLC 10% owner Conversion +4,859,370 4,859,370
2026-01-12 Vida Ventures II, LLC 10% owner Purchase +812,455 $18.00 $14.6M 5,671,825
2026-01-12 Vida Ventures II, LLC 10% owner Conversion +134,842 134,842
2026-01-12 Vida Ventures II, LLC 10% owner Purchase +22,545 $18.00 $406K 157,387
2026-01-12 Vida Ventures II, LLC 10% owner Conversion · Series A Redeemable Convertible Preferred Stock −14,838,250 0
2026-01-12 Vida Ventures II, LLC 10% owner Conversion · Series A Redeemable Convertible Preferred Stock −411,750 0
2026-01-12 Vida Ventures II, LLC 10% owner Conversion · Series B Redeemable Convertible Preferred Stock −3,648,750 0
2026-01-12 Vida Ventures II, LLC 10% owner Conversion · Series B Redeemable Convertible Preferred Stock −101,250 0
2026-01-12 Segal Lloyd Mitchell Director Conversion +19,631 19,631
2026-01-12 Segal Lloyd Mitchell Director Conversion · Series A Redeemable Convertible Preferred Stock −50,000 0
2026-01-12 Segal Lloyd Mitchell Director Conversion · Series B Redeemable Convertible Preferred Stock −24,687 0
2026-01-12 Kim Helen Susan Director Conversion +4,859,370 4,859,370
2026-01-12 Kim Helen Susan Director Purchase +812,455 $18.00 $14.6M 5,671,825
2026-01-12 Kim Helen Susan Director Conversion +134,842 134,842
2026-01-12 Kim Helen Susan Director Purchase +22,545 $18.00 $406K 157,387

Page 3 of 4 · 76 trades